Health Condition 1: I21- Acute myocardial infarction Health Condition 2: I20- Angina pectoris Health Condition 3: I23- Certain current complications following ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction (within the 28 day period) Health Condition 4: I25- Chronic ischemic heart disease Health Condition 5: I24- Other acute ischemic heart diseases Health Condition 6: I22- Subsequent ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. All patients undergoing percutaneous coronary intervention through femoral route 2. Provide a written, informed consent to take part in the study
Exclusion criteria
Exclusion criteria: 1. Clinical instability with compromised hemodynamics including (not restricted to) Symptomatic decompensated heart failure, Cardiogenic shock or Compromised rhythm requiring intravenous medication or temporary pacemaker 2.Mentally unstable patient (who would not be able to communicate his/her symptoms reliably) 3.Uncontrolled co-morbidities like (non restricted to) uncontrolled DM, accelerated hypertension (HTN), chronic kidney disease with fluid overload 4.Procedural complications like perforation, dissection (non stented type C-F dissection), less than optimal angiographic flow on revascularization, occlusion of a significant side branch during PCI. 5.Supported PCI (requiring ventricular support system) 6.Hemodynamic compromise during PCI 7.Post procedure: hemodynamic compromise, arrhythmias, recurrent chest pain, local site complications including (not restricted to) significant local site bleeding requiring blood transfusion, significant hematoma (>= 5 cm), significant non access site bleeding 8.Absence of responsible care giver at home 9.Inability to reach the medical centre in case of emergency (lack of reliable transport system) 10.Patient or family refusal
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To determine the safety and feasibility of SDD with and without the use of suture mediated closure devices in post-PCI patients.Timepoint: At time of discharge, 1 day post discharge, 6 weeks post discharge | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the patients of manual compression with suture mediated device closure for the safety and efficacy of SDD.Timepoint: At time of discharge, 1 day post discharge, 6 weeks post discharge | — |
Countries
India
Contacts
PGIMER, Chandigarh